Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 8
- Exclusivities
- 3
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.
| Dosage form | NDCs |
|---|---|
| kit | 2 |
| tablet | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| phathom pharmaceuticals inc. | 4 |
Exclusivity
Patents and exclusivities
8| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7977488 | VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAKamoxicillin; clarithromycin; vonoprazan fumarate; amoxicillin; vonoprazan fumarate; vonoprazan fumarate | substance | Apr 2030 |
| 9186411 | VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAKamoxicillin; clarithromycin; vonoprazan fumarate; amoxicillin; vonoprazan fumarate; vonoprazan fumarate | product | Aug 2030 |
| Product | Exclusivity | Until |
|---|---|---|
| VOQUEZNAVONOPRAZAN FUMARATE | GAIN Qualified infectious disease product (GAIN) | May 2032 |
| VOQUEZNA DUAL PAKAMOXICILLIN; VONOPRAZAN FUMARATE | GAIN Qualified infectious disease product (GAIN) | May 2032 |
| VOQUEZNA TRIPLE PAKAMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE | GAIN Qualified infectious disease product (GAIN) | May 2032 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| VOQUEZNA | vonoprazan fumarate | tablet, oral | 81520-100NDA |
| VOQUEZNA | vonoprazan fumarate | tablet, oral | 81520-200NDA |
| VOQUEZNA DUAL PAK | vonoprazan fumarate and amoxicillin | kit | 81520-250NDA |
| VOQUEZNA TRIPLE PAK | vonoprazan fumarate, amoxicillin and clarithromycin | kit | 81520-255NDA |
Enquiry
Common questions
- Is Phathom Pharmaceuticals Inc. FDA approved?
- Phathom Pharmaceuticals Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Phathom Pharmaceuticals Inc. make?
- 4 products are listed under Phathom Pharmaceuticals Inc. in the openFDA NDC Directory, most often as kit; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.